These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 32237901)

  • 1. Immune-epidemiological parameters of the novel coronavirus - a perspective.
    Saghazadeh A; Rezaei N
    Expert Rev Clin Immunol; 2020 May; 16(5):465-470. PubMed ID: 32237901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 (COVID-19): A literature review.
    Harapan H; Itoh N; Yufika A; Winardi W; Keam S; Te H; Megawati D; Hayati Z; Wagner AL; Mudatsir M
    J Infect Public Health; 2020 May; 13(5):667-673. PubMed ID: 32340833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 outbreak: What we know.
    Wu D; Wu T; Liu Q; Yang Z
    Int J Infect Dis; 2020 May; 94():44-48. PubMed ID: 32171952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
    Ahn DG; Shin HJ; Kim MH; Lee S; Kim HS; Myoung J; Kim BT; Kim SJ
    J Microbiol Biotechnol; 2020 Mar; 30(3):313-324. PubMed ID: 32238757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immune Response and Immunopathology of COVID-19.
    Mortaz E; Tabarsi P; Varahram M; Folkerts G; Adcock IM
    Front Immunol; 2020; 11():2037. PubMed ID: 32983152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
    Li H; Liu Z; Ge J
    J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China.
    Qi Z; Yu Y
    Curr Top Med Chem; 2020; 20(13):1137-1140. PubMed ID: 32394842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Novel Coronavirus: A Bird's Eye View.
    Habibzadeh P; Stoneman EK
    Int J Occup Environ Med; 2020 Apr; 11(2):65-71. PubMed ID: 32020915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Mediated Immune Responses to COVID-19 Infection.
    Guihot A; Litvinova E; Autran B; Debré P; Vieillard V
    Front Immunol; 2020; 11():1662. PubMed ID: 32719687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data Mining and Content Analysis of the Chinese Social Media Platform Weibo During the Early COVID-19 Outbreak: Retrospective Observational Infoveillance Study.
    Li J; Xu Q; Cuomo R; Purushothaman V; Mackey T
    JMIR Public Health Surveill; 2020 Apr; 6(2):e18700. PubMed ID: 32293582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
    Lu R; Zhao X; Li J; Niu P; Yang B; Wu H; Wang W; Song H; Huang B; Zhu N; Bi Y; Ma X; Zhan F; Wang L; Hu T; Zhou H; Hu Z; Zhou W; Zhao L; Chen J; Meng Y; Wang J; Lin Y; Yuan J; Xie Z; Ma J; Liu WJ; Wang D; Xu W; Holmes EC; Gao GF; Wu G; Chen W; Shi W; Tan W
    Lancet; 2020 Feb; 395(10224):565-574. PubMed ID: 32007145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2019-nCoV: new challenges from coronavirus].
    Tian HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):235-238. PubMed ID: 32187929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.
    Haider N; Yavlinsky A; Simons D; Osman AY; Ntoumi F; Zumla A; Kock R
    Epidemiol Infect; 2020 Feb; 148():e41. PubMed ID: 32100667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
    Rokni M; Ghasemi V; Tavakoli Z
    Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.